Virginia House Bill HB239

Virginia 2024 Regular Session

• Introduced: 1/4/24
• Refer: 1/4/24

Caption

Sickle Cell Disease, Advisory Council on; established, report.

Impact

The impact of HB239 on state laws is primarily the formal establishment of the Council, which will have the authority to advise the Commissioner on matters related to sickle cell disease. The legislature mandates annual reports that will track the Council's recommendations and activities, ensuring that relevant stakeholders and the public remain informed about the progress and challenges in addressing sickle cell disease in Virginia.

Summary

House Bill 239 establishes the Advisory Council on Sickle Cell Disease within the Virginia state government, aimed at improving awareness and addressing the needs of individuals affected by sickle cell disease and sickle cell trait. The Council is comprised of seven nonlegislative citizen members appointed by the Governor, including healthcare providers, community representatives, and individuals with lived experience of the disease. This structure is designed to ensure that a diverse array of perspectives informs the Council's recommendations and actions.

Contention

While the bill may generally be seen as a positive step towards enhancing healthcare and awareness for sickle cell disease, there could be contention around the allocation of funding and resources necessary to effectively support the Council's operations. Critics may argue about the efficacy of such councils in producing tangible improvements in public health or might question the representation of certain voices in the appointing process. Further discussions will likely focus on how these efforts translate into improved health outcomes for the affected community.